"Cell and gene therapies are gradually becoming more important...
Category:
Health
Latest
Focus shifts to healthcare delivery in 2023 as Covid stress eases
A total of 6.11 crore hospital admissions involving expenditure of...
Indian health insurance industry anticipates a transformative 2024
Prasun Sikdar, MD and CEO, ManipalCigna Health Insurance The...
After COVID-19, ‘black fungus’ robs some in India of their eyesight
After a catastrophic second wave of COVID-19 in India since April which has seen its overall death toll climb to almost 400,000, thousands who contracted the virus also suffered from a rare fungal disease called mucormycosis, or “black fungus”.
Data, demographic dividend present huge opportunity; this decade to be ‘India’s techade’: PM
He cited an example of how Digilocker has helped millions of people especially during the pandemic by providing a digital storage facility for school certificates, medical documents and other important certificates.
Modi highlighted that 2.5 lakh CSCs had helped take the Internet to remote areas. Under Bharat Net scheme, work is underway on a mission mode to bring broadband internet to the villages.
Dr Reddy’s denied approval for Phase 3 trials of Sputnik Light vaccine
“The Subject Expert Committee has denied permission to Dr Reddy’s to conduct phase-3 trials on the Russian vaccine Sputnik Light in India,” sources told ANI here.
After launching Sputnik V, Russia had introduced a new single-dose vaccine called Sputnik Light in May.
Digit Insurance profit falls 30% to 123 crore in 2020-21, combined ratio at 109.4%
The insurer is raising $200 million from new investors Sequoia Capital India and IIFL Alternate Asset Managers as well as existing investor Faering Capital and others in a round expected to generate a valuation of $3.5 billion, said a statement by the company.
Andhra CM launches ‘YSR Bima’ scheme, allocates Rs 750 crore for 2021-22
“Similarly, as promised during elections, the government had brought YSR Bima, an insurance scheme to support those families who lost their breadwinner. About 1.30 lakh families have been brought under insurance coverage. Under the scheme, an insurance amount of Rs 1 lakh will be paid if the beneficiary aged between 18 to 50 years, who is a breadwinner of the family, succumbs to natural death. A sum of Rs 5 lakh will be paid if the beneficiary in the age group of 18 to 70 years dies in an accident”, said the Chief Minister.
India’s medical infra well prepared to deal with third COVID wave: FM
A Rs 50,000 crore credit guarantee scheme for setting up of medical or health infrastructure by private hospitals in cities other than 8 metropolitan cities was also announced as part of measures for reviving the economy battered by a severe second wave of COVID-19.
The minister further said 45-50 lakh people per day are getting vaccinated and a total of 33 crore people have received vaccination.
Insurers got 22k claims for COVID-19 deaths in FY21; no significant impact on sector financials:RBI
The claims paid ratio (provisional) stood at 98.1 per cent for individual claims and 98.6 per cent in the group category, in comparison with 96.8 per cent and 97.3 per cent, respectively, for the previous financial year, it said.
”…the pandemic did not have a significant impact on death claim settlement rates,” it said.
Generation Equality: Alongside COVID lies an ‘equally horrific pandemic’ threatening women
And compared to men, women are 24 per cent more likely to lose their jobs and can expect their income to fall by 50 per cent more – making economic justice and rights imperative.
At the same time, women are 10 per cent less likely than men to have internet access, leaving 433 million women globally on “mute”.
India’s Zydus Cadila seeks approval for its 3-dose COVID vaccine
Zydus said the efficacy result is based on an interim analysis of a late-stage trial of more than 28,000 volunteers nationwide, including nearly 1,000 subjects in the age group of 12 to 18.
Immunogenicity data for the adolescent children subset will be submitted in the next four to six weeks, Patel said.
Not much data on Delta plus variant to suggest it’s more infectious, causes more deaths: Delhi AIIMS director
“There isn’t much data on Delta plus variant to suggest it’s more infectious, causing more deaths, or has developed significant immune escape mechanism. But if we follow COVID appropriate behaviour and get vaccinated, we’ll be safe against any of emerging variants,” Dr Guleria told ANI.